Rise Therapeutics enrols first patient in trial of type 1 diabetes drug R-5280
US-based biotechnology company Rise Therapeutics has enrolled the first subject in a Phase Ib trial to determine the safety and…
US-based biotechnology company Rise Therapeutics has enrolled the first subject in a Phase Ib trial to determine the safety and…
US-based biotechnology company Cytonics has started a Phase I clinical trial of a new therapeutic for osteoarthritis of the knee.…
Chinese biotechnology company Eluminex Biosciences has dosed the first patient with its trispecific fusion antibody, EB-105, in the Phase I…
Swedish pharmaceutical company Camurus has reported positive results from the Phase III ACROINNOVA 2 study, which assessed the efficacy and…
Nona Biosciences has partnered with biotechnology company Alaya.bio to advance CAR-T cell therapies. The partnership will combine Nona's HCAb Harbour…
Abu Dhabi-based contract research organisation and a part of the M42 group, IROS has announced a collaboration with Prilenia Therapeutics…
South Korean biopharmaceutical company Rznomics is set to begin a Phase I/IIa clinical trial of RNA editing therapy, RZ-004, for…
Biopharmaceutical company Sirnaomics has completed the investigational new drug (IND)-enabling studies of the safety and efficacy of STP125G, a small…
Verastem Oncology has announced the dosing of the first patient with GFH375/VS-7375, a potent and selective oral KRAS G12D (ON/OFF)…
Tr1X has dosed the first patient as part of the TRX103-01 clinical trial to assess TRX103, a Type 1 Treg…